-
Mashup Score: 2
“In terms of the minimal overlapping toxicity, our non-clinical data from the xenograft model showed minimal toxicity with the combination,” says Caroline Foxton, PhD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
Dr. Caroline Foxton discusses findings of cobimetinib in combination with 177Lu-rhPSMA-10.1 for prostate cancer. #pcsm #cancerresearch #urology Read here: https://t.co/Ck67hZq3Ci